Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


New device use updates on French agency website:

This article was originally published in Clinica

Executive Summary

Recent medical device updates featured on the website of the French healthcare product safety agency AFSSaPS concern Ela Medical's Alto implantable defibrillators and Gambro's Select Bags for glucose used in haemodialysis. Ela Medical is informing doctors responsible for the follow-up of patients receiving its Alto devices that it now has a new version software programme for the defibrillator which will help during the three-month follow-up of patients to check the performance of the batteries, which have given cause for concern in the past. Gambro's update concerns the handling of the haemodialysis concentrate in double compartment Select Bags.





Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts